Associate Director, Study Feasibility

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow.

We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio.

For more information about AbbVie, please visit us at www.abbvie.com.

Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

As a Study Feasibility Associate Director, you will be part of AbbVie’s Clinical Development Operations (CDO) function, which is responsible for running clinical trial operations around the world.

In this role you will partner with and advise study teams on design feasibility and certain aspects of design strategy, including country and site selection, protocol review and assessment of patient burden, and related implications for patient recruitment and study timelines.

This is a highly collaborative and analytical role, which will rely on your expert facilitation skills, your ability to influence without authority, and your strong experience in clinical study design, operations, and management.

• Dynamic leader who designs, prepares, and facilitates cross-functional global strategy discussions that can include 20 or more senior level AbbVie leaders to assess operational feasibility and optimize/develop effective execution strategies.
• Responsible to support strategic planning for delivery of global phase 2 and phase 3 clinical trials within Abbvie portfolio. Large Scale studies may be conducted in over 35 countries, supported by teams of 250 or more AbbVie study team members with study budgets exceeding 200 million dollars.
• Responsible for matrix management to help drive analytical insights and study recruitment planning across multiple AbbVie functional teams.
• Conducts detailed scientific, analytical, and operational analyses to prepare for and support study team engagements.
• Provides scientific and strategic consultation on country strategy, site selection, protocol and patient burden, recruitment, and timelines.
• Identifies and analyzes important connections within and across therapeutic areas to optimize study performance at the portfolio level.